Zobrazeno 1 - 10
of 176
pro vyhledávání: '"J.F. Bosset"'
Autor:
Gilles Créhange, Zaher Lakkis, Stefano Kim, Hatem Boulahdour, J.F. Bosset, Christophe Borg, B. De Bari, M. De Billy, D. Aloi
Publikováno v:
Cancer/Radiothérapie. 22:718-719
Objectif de l’etude Definir l’impact de la TEP-scanographie et de l’IRM dans le suivi des patients atteints d’un cancer anal pris en charge par chimioradiotherapie selon le schema de l’European Organisation for Research and Treatment of Can
Autor:
D. Aloi, Gilles Créhange, J.F. Bosset, C. Reichling, Zaher Lakkis, Stefano Kim, B. De Bari, Alexis Lepinoy, C. Teyssier
Publikováno v:
37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO)
37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), European Society of Radiotherapy & Oncology, Apr 2018, Barcelone, Spain. pp.S814-S815, ⟨10.1016/S0167-8140(18)31811-5⟩
37th Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), European Society of Radiotherapy & Oncology, Apr 2018, Barcelone, Spain. pp.S814-S815, ⟨10.1016/S0167-8140(18)31811-5⟩
International audience
Autor:
A. Briffaux, J.F. Bosset, L. Radosevic-Jelic, Gilles Calais, Alain Daban, Etienne Bardet, Marianne Pierart, P. Maingon, C. Berger
Publikováno v:
European Journal of Cancer. 40:219-224
The European Organisation for Research and Treatment of Cancer (EORTC) 22921 four-arm randomised trial questioned the value of preoperative chemoradiation (XRT-CT) versus preoperative radiation (XRT) and the value of additional postoperative chemothe
Autor:
J.F. Bosset, Gilles Créhange, J. Buffet miny, A. Lépinoy, M. Puyraveau, C. Teyssier, Z. Barhtot
Publikováno v:
Cancer/Radiothérapie. 20:729-730
Objectif de l’etude La chimioradiotherapie est un traitement standard dans le traitement du cancers du canal anal mais peu evalue chez le sujet âge. L’etude de l’European Organization for Research and Treatment of Cancer (EORTC) 22953 a evalue
Autor:
Aurélie Bertaut, Gilles Créhange, Christophe Borg, J. Buffet Miny, François Ghiringhelli, J.F. Bosset, Jihane Boustani, B. De Bari, M. Rouffiac
Publikováno v:
Radiotherapy and Oncology. 123:S671
Autor:
M. Untereiner, Marianne Pierart, J.F. Bosset, Harry Bartelink, E Ciambelloti, Robert J.L. Caspers, M. van Glabbeke, Jean-Claude Horiot, Luca Cionini, H.P. Hamers
Publikováno v:
Radiotherapy and Oncology. 61:7-13
The purpose of this randomized multicenter study was to assess the impact on disease free and overall survival of low dose irradiation to para-aortic nodes and liver in patients with a locally advanced resected rectal cancer receiving a 50 Gy postope
Autor:
J.F. Bosset
Publikováno v:
Cancer/Radiothérapie. 9:137-139
Autor:
J. Santini, X.S. Sun, J.F. Bosset, Sandra Lassalle, S.R. Sun, Nicolas Fakhry, René-Jean Bensadoun, Juliette Thariat, N. Guevara, Pierre Yves Marcy
Publikováno v:
Radiotherapy and Oncology. 106
Publikováno v:
Bulletin du Cancer/Radiothérapie. 82:94-97
Autor:
Xu Shan Sun, P.-Y. Marcy, Nicolas Guevara, Alexis Lacout, J.F. Bosset, René-Jean Bensadoun, S.R. Sun, Juliette Thariat, Isabelle Peyrottes, Sandra Lassalle, L. Cals, Adam S. Garden, Nicolas Fakhry, J. Santini
Publikováno v:
Critical reviews in oncology/hematology. 86(3)
Background ATC represents 1–2% of all thyroid carcinomas. Median survival is poor (3–10 months). Our goal is to update recommendations for RT in the context of new irradiation techniques. Materials and methods A search of the French and English l